Regulators of G-protein signaling 4 in adrenal gland: localization, regulation, and role in aldosterone secretion.
暂无分享,去创建一个
C. Gomez-Sanchez | E. Gomez-Sanchez | D. Romero | M. Plonczynski | Licy L. Yanes | Mingyi Zhou | Tanganika R Washington
[1] D. Levy,et al. Clinical and Genetic Correlates of Aldosterone-to-Renin Ratio and Relations to Blood Pressure in a Community Sample , 2007, Hypertension.
[2] C. Gomez-Sanchez,et al. RGS2 is regulated by angiotensin II and functions as a negative feedback of aldosterone production in H295R human adrenocortical cells. , 2006, Endocrinology.
[3] D. Rizzoni,et al. Renal Damage in Primary Aldosteronism: Results of the PAPY Study , 2006, Hypertension.
[4] P. Chidiac,et al. RGS proteins have a signalling complex: interactions between RGS proteins and GPCRs, effectors, and auxiliary proteins. , 2006, Cellular signalling.
[5] U. Walter,et al. Regulation of aldosterone production from zona glomerulosa cells by ANG II and cAMP: evidence for PKA-independent activation of CaMK by cAMP. , 2006, American journal of physiology. Endocrinology and metabolism.
[6] J. Lehoux,et al. Novel protein kinase C-epsilon inhibits human CYP11B2 gene expression through ERK1/2 signalling pathway and JunB. , 2006, Journal of molecular endocrinology.
[7] S. Lanier,et al. Accessory proteins for G proteins: partners in signaling. , 2006, Annual review of pharmacology and toxicology.
[8] Min Jae Lee,et al. RGS4 and RGS5 are in vivo substrates of the N-end rule pathway. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[9] B. Schimmer,et al. Adrenocortical cell lines , 2004, Molecular and Cellular Endocrinology.
[10] S. Heximer,et al. G-protein signaling participates in the development of diabetic cardiomyopathy. , 2004, Diabetes.
[11] C. Gomez-Sanchez,et al. Angiotensin II early regulated genes in H295R human adrenocortical cells. , 2004, Physiological genomics.
[12] D. Levy,et al. Serum aldosterone and the incidence of hypertension in nonhypertensive persons. , 2004, The New England journal of medicine.
[13] L. Hunyady,et al. Control of aldosterone secretion: a model for convergence in cellular signaling pathways. , 2004, Physiological reviews.
[14] J. Leysen,et al. Dopamine receptor‐mediated regulation of RGS2 and RGS4 mRNA differentially depends on ascending dopamine projections and time , 2004, The European journal of neuroscience.
[15] P. White,et al. The regulation of aldosterone synthase expression , 2004, Molecular and Cellular Endocrinology.
[16] C. Larminie,et al. Selective expression of regulators of G-protein signaling (RGS) in the human central nervous system. , 2004, Brain research. Molecular brain research.
[17] Michael Gill,et al. Confirming RGS4 as a susceptibility gene for schizophrenia , 2004, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[18] Michael J Owen,et al. Recent advances in the genetics of schizophrenia. , 2003, Human molecular genetics.
[19] A. Smrcka. G Protein Signaling , 2003 .
[20] P. Chidiac,et al. Recruitment of RGS2 and RGS4 to the plasma membrane by G proteins and receptors reflects functional interactions. , 2003, Molecular pharmacology.
[21] J. Kehrl,et al. The aorta and heart differentially express RGS (regulators of G-protein signalling) proteins that selectively regulate sphingosine 1-phosphate, angiotensin II and endothelin-1 signalling. , 2003, The Biochemical journal.
[22] C. Gomez-Sanchez,et al. Interferon-inducible genes in the rat adrenal gland and vascular smooth muscle cells , 2003, Molecular and Cellular Endocrinology.
[23] T. Wieland,et al. Expression of ten RGS proteins in human myocardium: functional characterization of an upregulation of RGS4 in heart failure. , 2002, Cardiovascular research.
[24] J. Hepler,et al. Cellular Regulation of RGS Proteins: Modulators and Integrators of G Protein Signaling , 2002, Pharmacological Reviews.
[25] W. Rainey,et al. Calmodulin-dependent kinase I regulates adrenal cell expression of aldosterone synthase. , 2002, Endocrinology.
[26] B. Devlin,et al. Association and linkage analyses of RGS4 polymorphisms in schizophrenia. , 2002, Human molecular genetics.
[27] T. Ingi,et al. Expression of RGS2, RGS4 and RGS7 in the developing postnatal brain , 2002, The European journal of neuroscience.
[28] Richard R. Neubig,et al. Regulators of G-Protein signalling as new central nervous system drug targets , 2002, Nature Reviews Drug Discovery.
[29] M. Yacoub,et al. Expression of RGS3, RGS4 and Gi alpha 2 in acutely failing donor hearts and end-stage heart failure. , 2001, European heart journal.
[30] M. Pfaffl,et al. A new mathematical model for relative quantification in real-time RT-PCR. , 2001, Nucleic acids research.
[31] D. Lewis,et al. Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia , 2001, Molecular Psychiatry.
[32] J. Lehoux,et al. Control of CYP11B2 Gene Expression through Differential Regulation of Its Promoter by Atypical and Conventional Protein Kinase C Isoforms* , 2001, The Journal of Biological Chemistry.
[33] A. Varshavsky,et al. RGS4 Is Arginylated and Degraded by the N-end Rule Pathway in Vitro * , 2000, The Journal of Biological Chemistry.
[34] Anthony J. Muslin,et al. RGS4 causes increased mortality and reduced cardiac hypertrophy in response to pressure overload. , 1999, The Journal of clinical investigation.
[35] W. Yokoyama,et al. Production of Monoclonal Antibodies , 1999, Current protocols in cytometry.
[36] S. Bornstein,et al. Local renin-angiotensin system is involved in K+-induced aldosterone secretion from human adrenocortical NCI-H295 cells. , 1999, Hypertension.
[37] Anthony J. Muslin,et al. RGS4 inhibits G-protein signaling in cardiomyocytes. , 1999, Circulation.
[38] C. Gomez-Sanchez,et al. Development of Adrenal Zonation in Fetal Rats Defined by Expression of Aldosterone Synthase and 11β-Hydroxylase. , 1998, Endocrinology.
[39] C. Barnes,et al. Dynamic Regulation of RGS2 Suggests a Novel Mechanism in G-Protein Signaling and Neuronal Plasticity , 1998, The Journal of Neuroscience.
[40] I. Bird,et al. Battle of the kinases: integration of adrenal responses to cAMP, DG and Ca2+ at the level of steroidogenic cytochromes P450 and 3betaHSD expression in H295R cells. , 1998, Endocrine research.
[41] J. Lehoux,et al. Transcriptional activity of the hamster CYP11B2 promoter in NCI-H295 cells stimulated by angiotensin II, potassium, forskolin and bisindolylmaleimide. , 1998, Journal of molecular endocrinology.
[42] J. Rottman,et al. RGS3 and RGS4 are GTPase activating proteins in the heart. , 1998, Journal of molecular and cellular cardiology.
[43] A. Gilman,et al. Mammalian RGS Proteins: Barbarians at the Gate* , 1998, The Journal of Biological Chemistry.
[44] T. Yoshimoto,et al. Left ventricular hypertrophy is more prominent in patients with primary aldosteronism than in patients with other types of secondary hypertension. , 1997, Hypertension research : official journal of the Japanese Society of Hypertension.
[45] G. Guillemette,et al. Stimulation of the angiotensin II type I receptor on bovine adrenal glomerulosa cells activates a temperature-sensitive internalization-recycling pathway , 1997, Molecular and Cellular Endocrinology.
[46] P. Palatini,et al. Remodeling of the left ventricle in primary aldosteronism due to Conn's adenoma. , 1997, Circulation.
[47] S. Andò,et al. Ca2+-Regulated Expression of Aldosterone Synthase Is Mediated By Calmodulin and Calmodulin-Dependent Protein Kinases. , 1997, Endocrinology.
[48] Rachida Ouali,et al. Angiotensin II Receptor Subtypes AT1 and AT2 Are Down-Regulated by Angiotensin II through AT1 Receptor by Different Mechanisms. , 1997, Endocrinology.
[49] A. Gilman,et al. RGS4 and GAIP are GTPase-activating proteins for Gq alpha and block activation of phospholipase C beta by gamma-thio-GTP-Gq alpha. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[50] A. Gilman,et al. The GTPase-activating Protein RGS4 Stabilizes the Transition State for Nucleotide Hydrolysis* , 1996, The Journal of Biological Chemistry.
[51] K. Blumer,et al. RGS family members: GTPase-activating proteins for heterotrimeric G-protein α-subunits , 1996, Nature.
[52] J. Mathis,et al. Differential regulation of 11 beta-hydroxylase and aldosterone synthase in human adrenocortical H295R cells. , 1996, Molecular and cellular endocrinology.
[53] A. Ganguly,et al. Role of calcium and other mediators in aldosterone secretion from the adrenal glomerulosa cells. , 1994, Pharmacological reviews.
[54] G. Guillemette,et al. Short-term desensitization of the angiotensin II receptor of bovine adrenal glomerulosa cells corresponds to a shift from a high to a low affinity state. , 1994, Endocrinology.
[55] I. Bird,et al. Regulation of type 1 angiotensin II receptor messenger ribonucleic acid expression in human adrenocortical carcinoma H295 cells. , 1994, Endocrinology.
[56] I. Bird,et al. The NCI-H295 cell line: a pluripotent model for human adrenocortical studies , 1994, Molecular and Cellular Endocrinology.
[57] J. Mathis,et al. Human NCI-H295 adrenocortical carcinoma cells: a model for angiotensin-II-responsive aldosterone secretion. , 1993, Endocrinology.
[58] R. Benarous,et al. Characterization and regulation of the angiotensin II type‐1 receptor (binding and mRNA) in human adrenal fasciculata‐reticularis cells , 1993, FEBS letters.
[59] L. Buday,et al. The role of protein kinase-C in control of aldosterone production by rat adrenal glomerulosa cells: activation of protein kinase-C by stimulation with potassium. , 1992, Endocrinology.
[60] T. Rink,et al. SK&F 96365, a novel inhibitor of receptor-mediated calcium entry. , 1990, The Biochemical journal.
[61] H. Rasmussen,et al. Role of calcium in angiotensin II-mediated aldosterone secretion. , 1989, Endocrine reviews.
[62] A. Crozat,et al. Regulation of angiotensin II receptors and steroidogenic responsiveness in cultured bovine fasciculata and glomerulosa adrenal cells. , 1988, European journal of biochemistry.
[63] C. Gomez-Sanchez,et al. The production of monoclonal antibodies against aldosterone , 1987, Steroids.
[64] M. Cantin,et al. Fate of [125I]angiotensin II in adrenal zona glomerulosa cells. , 1986, Endocrinology.
[65] P. Insel,et al. Regulation of G Protein–Coupled Receptor Signaling By Scaffold Proteins G Protein–Coupled Receptor Oligomerization: Implications for G Protein Activation and Cell Signaling Multi-Tasking RGS Proteins in the Heart: The Next Therapeutic Target? , 2005 .
[66] E M Ross,et al. GTPase-activating proteins for heterotrimeric G proteins: regulators of G protein signaling (RGS) and RGS-like proteins. , 2000, Annual review of biochemistry.
[67] S Rozen,et al. Primer3 on the WWW for general users and for biologist programmers. , 2000, Methods in molecular biology.
[68] M. Farquhar,et al. The regulator of G protein signaling family. , 2000, Annual review of pharmacology and toxicology.
[69] L. de Vries,et al. RGS proteins: more than just GAPs for heterotrimeric G proteins. , 1999, Trends in cell biology.
[70] J. Saez,et al. Angiotensin Ii Receptor Subtypes At1 and At2 Are Down-regulated by Angiotensin Ii through At1 Receptor by Different Mechanisms* , 2022 .
[71] K. Blumer,et al. RGS family members: GTPase-activating proteins for heterotrimeric G-protein alpha-subunits. , 1996, Nature.